|
Neonatal Intensive Care Drug Manual
|
| bet | 421/654 | | Sana | 03.01.2022 | | Hajmi | 1,5 Mb. | | #14803 |
Dosage/Interval
|
Muscle relaxation
IV bolus: 0.1 mg/kg followed by
Either IV infusion 0.05 mg/kg/hour (0.025–0.075 mg/kg/hour) OR
Intermittent IV bolus 0.05 mg/kg (0.05–0.1 mg/kg) every 1–2 hours.
Note: IV infusion dose can be increased or decreased by 0.01 mg/kg/hour to a maximum of 0.1 mg/kg/hour.
Intubation
IV bolus: 0.1 mg/kg.
|
Maximum dose
|
IV bolus: 0.1 mg/kilogram/dose.
|
Route
|
IV
|
Preparation/Dilution
|
IV bolus:
Draw up 2 mL (4 mg of pancuronium) and add 6 mL water for injection to make a final volume of 8 mL with a concentration of 0.5 mg/mL
IV infusion:
Infusion rate
|
Prescribed amount
|
1 mL/hour = 50 microgram/kg/hour
|
2.5 mg/kg of pancuronium and make up to 50 mL
|
Draw up 1.25 mL/kg (2.5 mg/kg of pancuronium) and add sodium chloride 0.9% to make a final volume of 50 mL. Infusing at a rate of 1 mL/hour = 50 microgram/kg/hour.
|
Administration
|
IV bolus: Administer as a rapid intravenous injection over several seconds.
Line should be adequately flushed to avoid unintended paralysis during later use of the line.
|
Monitoring
|
Continuous cardio-respiratory and pulse oximetry monitoring. Close monitoring of neuromuscular function, sedation and blood pressure (invasive or non-invasive) is essential. Monitoring of fluid balance is essential due to of risk of fluid retention. Monitor hepatic and renal function with prolonged use.
|
|
|
| |
